04:00 PM EDT, 03/18/2025 (MT Newswires) -- Health care stocks rose late Tuesday afternoon with the NYSE Health Care Index adding 0.3% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%.

The iShares Biotechnology ETF (IBB) fell 1.4%.

In corporate news, Sarepta Therapeutics ( SRPT ) shares slumped 27% after a young patient with Duchenne muscular dystrophy died of acute liver failure following treatment with the company's Elevidys gene therapy.

TC BioPharm ( TCBP ) plans to outsource various functions and switch to a "more decentralized" model, resulting in a workforce reduction of 20 employees. The shares fell 4.6%.

Aditxt ( ADTX ) shares surged 70% after its acquisition target Appili Therapeutics submitted four new federal funding proposals totaling $117.5 million.

Can-Fite BioPharma ( CANF ) shares jumped 24% after the US Food and Drug Administration approved compassionate use treatment with the company's anticancer drug Namodenoson for a pancreatic cancer patient in the US.